BACKGROUND: Osteoporosis, the most common extra-pulmonary complication of chronic obstructive pulmonary disease (COPD), may be related to general causes or COPD-specific causes such as low forced expiratory volume in 1 s (FEV1) and hypoxia. A few studies reported that emphysema is an independent risk factor for osteoporosis. However, other workers considered the association to be confounded by low FEV1 and low body mass index (BMI) which cluster with emphysema.
C hronic obstructive pulmonary disease (COPD), a leading cause of morbidity and mortality, is associated with serious extrapulmonary comorbidities. The most frequent of these is bone disease: osteoporosis has an overall prevalence of 35.1% (range: 9%-69%) as reported in a review of 13 studies on COPD patients. [1] In addition, 38.4% (range: 27%-67%) suffered from osteopenia. [1] Epidemiological studies reported a 1.5-2-fold increased risk of osteoporosis in COPD subjects compared with controls. [2, 3] Vertebral fractures in osteoporotic COPD are most common in the midthoracic region, which not only worsen the quality of life but have also a negative impact on the lung physiology. [4] It was estimated that each thoracic vertebral fracture results in a 9% decline of the lung vital capacity. [5] Osteoporosis in COPD is attributed to general causes such as age, low body mass index (BMI), corticosteroid use or hypogonadism or COPD-specific causes. [6] The latter include the stage of COPD as measured by forced expiratory volume in 1 s (FEV1), respiratory failure, the severity of dyspnea, and COPD phenotype as assessed by CT scan (emphysematous versus nonemphysematous). [6] [7] [8] [9] There is growing interest in phenotyping as various studies documented that emphysema is associated with lower FEV1, worse dyspnea score, and lower BMI. [10] [11] [12] Four studies reported that emphysema was a risk factor for osteoporosis independent of age, BMI or the stage of the lung disease. [4, 9, 13, 14] The association was called ""Holes in the lungs, holes in the bones!" [15] It was speculated that the common link between osteoporosis and emphysema was the heightened inflammatory markers in the two conditions. [16] However, other authors expressed doubts and considered low FEV1 and wasting (which cluster with emphysema) and not emphysema to be the trigger for osteoporosis.
[17] It is interesting that the serum levels of C-reactive protein (CRP) (an inflammatory marker linked to both COPD and osteoporosis) was reported to be lower in the emphysema phenotype than the peribronchial thickening/bronchiectasis phenotype of COPD. [18] Although some studies documented a positive association between the inflammatory markers and osteoporosis, the longitudinal Framingham Offspring Study found no consistent association between osteoporosis and serum levels of interleukin-6, tumor necrosis factor-alpha (TNF-α), or CRP. [19] The aim of this study is to delineate the COPD specific causes of osteoporosis and to test the hypothesis that emphysema is not a risk factor independent of low FEV1 and BMI. The differences between the various phenotypes of COPD are attracting new interest. To the best of our knowledge, no study has ever reported on the effect of emphysema on osteoporosis in a model that included together the potentially confounding factors of FEV1, BMI, and hypoxia. Vertebral fracture score and bone mass density (BMD) will be used as indicators of osteoporosis.
Methods

Patient selection and pulmonary function tests
The study was conducted at the teaching hospital of King Saud University, Riyadh, Saudi Arabia between 2011 and 2015 on all consecutive patients with COPD managed in the Pulmonology clinic. The study's protocol was approved by the Ethics Committee of the University as a prospective descriptive study and written informed consent was obtained from all patients. The criteria were age 40 or above, history of a chronic cough and dyspnea, cigarette smoking of at least ten pack years, postbronchodilator FEV1/ forced vital capacity <70% and FEV1 <80% predicted.
[20} Tiotropium (Spiriva Handihaler; Boehringer Ingelheim; Ingelheim, Germany) 18 µg once daily was prescribed. As long-acting β-2 agonists were not licensed for single use in Saudi Arabia, all patients were started on budesonide 320 µg/formoterol 9 µg (Symbicort Turbuhaler; AstraZeneca; London, UK) twice daily. Spirometry was performed with reversibility, carbon monoxide transfer coefficient (KCO) and arterial blood gasses. A KCO <80% predicted was considered indicative of emphysema. Arterial puncture of the radial artery (after lignocaine infiltration) was performed by a trained pulmonology function technician. The preheparinized syringe was packed in ice and analyzed in the Central Laboratory at King Khalid University Hospital. The test was performed at the time of the first pulmonary function test while the patient is breathing room air.
High resolution computed tomography scan scoring of emphysema High-resolution computed tomography (HRCT) scanning was used (LightSpeed 16 or VCT XT; GE Medical Systems, Milwaukee, Wisconsin, USA). Full-volume acquisitions reconstructed every 2.5 mm were obtained throughout the entire thorax. Images were acquired employing a standard window setting (window level: −700 Hounsfield Units [HU]; window width 1500 HU). We used Goddard's quantitative visual scoring of emphysema (defined as areas of attenuation of the lung parenchyma). [21] Zero represented no abnormality; 0.5 score was given for 1-5% involvement; 1 was given for 6%-25% involvement; 2 for 26%-50%; 3 for 51%-75%; and 4 for 76% or more. All patients had to be free of bronchiectasis and interstitial lung disease on HRCT scan.
The same three observers (AAA, FAA-K, and a second clinician) scored three cuts at the following levels: arch of the aorta, bifurcation of the trachea, and one cut above the diaphragm. Emphysema was considered significant if the average scoring was ≥1. This was based on reports that the lowest 25% percentile for emphysema displays features of asthma. [22] Consensus was used to smooth out any inter-observer differences.
Measurement of bone mass density
BMD was measured at the lumbar spine (L2-L4) and femoral necks by dual X-ray absorptiometry (DEXA) bone scan. The average BMD of lumbar vertebrae BMD (V) and the worst of the right and left femoral neck sites BMD (N) was used for statistical analysis and designated BMD (V/N). The T-score, which represents the number of standard deviations of BMD from the reference value for healthy young adults, was the basis for diagnosing osteoporosis. According to the definition of the World Health Organization osteoporosis corresponded to a T-score of ≤−2.5 and osteopenia to a score of ≤−1 and >−2.5.
[23] DEXA bone scans were performed at least 6 months after stabilizing all the patients on the same dose of budesonide (320 µcg twice daily), and none received systemic corticosteroids for the same period.
Genant scoring of vertebral fractures
Vertebral fractures were evaluated by CT scan using the Genant semiquantitative score. [24] Normal vertebrae (Grade 0) show minimal deformity with a <20% reduction in anterior, middle, and posterior vertebral height. Grade 1 is defined as a reduction of 20%-25% in vertebral height. Grade 2 and Grade 3 vertebral fractures are, respectively, defined as reductions of >25%-40% and >40% in vertebral height. [24] Statistical methods Data were analyzed using SPSS PC+ version 21.0 (IBM Inc., Chicago, USA) statistical software. Descriptive statistics and standard deviations were used to describe the quantitative study variables. Student's t-test was used to compare mean values of quantitative variables between the emphysematous and nonemphysematous groups. Multiple linear regression analysis was used to identify the independent variables (age, BMI, FEV1% predicted, PaO 2 , emphysema score, CRP, and dyspnea score) related to BMD (V/N). A P ≤ 0.05 was considered statistically significant. The 95% confidence intervals (CIs) for Beta coefficients were reported to assess their precision. Beta is a regression coefficient which explains the linear relationship between outcomes (dependent) and independent variables.
Results
A total of 55 patients fulfilled the criteria. Only one patient was lost to follow-up, and another two did not show up for their BMD testing. There were only three female patients. The COPD was moderate (FEV1 ≥50% to <80% predicted) in 61%, severe or very severe (FEV1 <50% predicted) in 39% of cases. Two patients were on long-term home oxygen. A total of 36.5% had osteoporosis, and 34.6% had osteopenia. BMD was normal in only 28.8%. Table 1 
Discussion
The prevalence of osteoporosis and osteopenia in our study were 36.5% and 34.6%, respectively which is in line with the bulk of previous studies.
[ 1] In a univariate analysis, the emphysematous group was significantly older, with lower BMI, FEV1, and PaO 2 and higher dyspnea score compared with the nonemphysematous. However, there was no significant difference with regards to serum Vitamin D level, fracture score, CRP, BMD (V), BMD (N), or BMD (V/N). The multivariable regression model (incorporating age, BMI, FEV1, PaO 2 , emphysema score, dyspnea score, and CRP) showed that only reduced BMI, FEV1, and PaO 2 and were identified as independent risk factors for low BMD.
COPD was reported to be the leading cause of secondary osteoporosis. [25] The various studies on COPD reported conflicting results on the effect of various variables on BMD except for BMI where there is general agreement on its significance. [1, 6, 8, [26] [27] [28] A large meta-analysis of twelve studies found a reverse and nonlinear relationship between low BMI and osteoporotic fractures. [29] The mechanisms for such association are probably multifactorial. Low BMI is associated with muscle wasting which reduces the mechanical loading on the bones and worsens osteoporosis. [6, 7] Adipose tissue produces several bone-active adipokines such as leptin which enhances the proliferation of osteoblasts while inhibiting osteoclasts. [30, 31] Similarly, obesity is protective against osteoporosis even though it increases the risk of low-trauma fractures. [27] Apart from the general causes of osteoporosis, there are factors specific to COPD. [6] These are the stage of COPD as measured by FEV1, hypoxia, dyspnea score, and emphysema. [4, 8, 9, 13, 14, 26, 28] Similar to our findings studies are nearly unanimous on the presence of an association between FEV1 and the severity of osteoporosis. [2, 7, 26, 28] Although the stage of COPD was shown to be an independent risk factor for osteoporosis, it is likely that the association is further enhanced by other factors prevalent in advanced COPD such as cachexia, skeletal muscle weakness, and reduced mobility. [7, 32] We are aware of only two studies which failed to detect an association between BMD and FEV1. [14, 33] However, these two studies had enrolled only 30 and 19 patients with osteoporosis which may explain the lack of association. [14, 33] Hypoxia blocks the differentiation of osteoblasts while stimulating the action of osteoclasts. [34] Our literature search indicates that we are the first to report on a multivariate analysis showing PaO 2 to be an independent risk for low BMD. One study found no association between oxygen desaturation and osteoporosis. [33] However, that study had only 19 osteoporotic patients and 11 controls. [33] Similarly, the relationship between PaO 2 and oxygen saturation is not linear, and significant hypoxia may occur in the absence of desaturation. [35] Previous reports are divergent on whether the dyspnea score is a risk factor for osteoporosis. [8, 25] Four studies reported that emphysema is an independent risk factor for osteoporosis, also termed "holes in the lungs, holes in the bones" theory. [4, 9, [13] [14] [15] Ohara et al. used the percentage of the low-attenuation area (LAA%) on CT scan to diagnose emphysema in 65 male COPD patients. [9] They reported in 2008 that LAA% and BMI were predictive of BMD among age, BMI, smoking index, FEV1, arterial blood gasses, and LAA%. [9] The mean BMI was 21.3 ± 2.7. [9] A critical appraisal of the association suggested that low BMI and not emphysema is the cause of low BMD.
[17] CT-diagnosed emphysema, hypoxemia, low BMI (in spite of high caloric intake) and muscle wasting are known to cluster. [7, 8, 31, 36, 37] Furthermore, the LAA% used in the study is not specific to emphysema but overlaps with severe asthma (even in nonsmokers) and correlates inversely with FEV1. [38] Bon et al. reported in 2011 that the visual score of emphysema and female sex were the only factors that increased the likelihood of osteopenia/osteoporosis in multivariate logistic regression. [13] However, they did not explore the role of BMI, and 38% of their sample did not have airway obstruction (smokers "at risk" for COPD) who would not qualify nowadays for a diagnosis of COPD. [13] Recently Jaramillo et al. used LAA% −950 HU as an indicator of emphysema. [4] They reported an association between emphysema and BMD after adjusting for age, race, BMI, and the use of oral corticosteroids. [4] However, their model did not include FEV1 adjustment which may have biased the results. [4] The level of attenuation of − 950 HU is known to overlap with nonemphysematous obstructive lung disease. [38] The same methodology (LAA% −950 HU) was used by Bai et al. who reported in 2011 that LAA% and BMI were significantly different in the group with the lowest BMD. [14] Similarly, their model did not include FEV1. [14] In our study, the multivariate regression model included age, BMI, hypoxia and FEV1, which may explain why the association between emphysema and BMD was not significant.
A review in 2012 by Bon attempted an explanation as to why radiographic emphysema increased the risk of osteoporosis. [16] The first explanation offered is that both emphysema and osteoporosis are the result of high inflammatory load. [16] TNF-α, interleukins, and metalloproteinase were the inflammatory markers highlighted as potential candidates. [16] Metalloproteinase, interleukins, and CRP were shown to rise not only in the emphysematous phenotype but also in the bronchial thickening phenotype of COPD. [18, 39] Similarly, TNF-α far from being raised was shown in some studies to be significantly lower in emphysema. [39] Although some studies reported an association between osteoporosis and some inflammatory markers, the Framingham offspring longitudinal study found no consistent association in postmenopausal women between osteoporosis and serum levels of interleukin-6, TNF-α or CRP. [19] The second explanation offered in the review is that both emphysema and osteoporosis are autoimmune conditions. [16] The evidence for COPD being an autoimmune condition is tenuous and not widely endorsed. Although a third of patients with stable COPD display abnormal titers of antinuclear and anti-tissue antibodies, these were not specific to the emphysema phenotype and were considered to be the result and not the cause of tissue destruction. [40] [41] [42] More specific antibodies aimed at elastin were considered to be potential inducers of emphysema. However, several studies could not identify antielastin antibodies or their levels in plasma or bronchoalveolar lavage were not elevated compared to controls. [43] [44] [45] The review and its references cite the osteoporosis of rheumatoid arthritis, lupus, and celiac disease as conditions where auto-antibodies have been "associated" with low BMD. [16] Even in these exclusively autoimmune conditions, osteoporosis is multifactorial as there exist no antibodies directed against bone tissue. The review also failed to address the role of severity of COPD and cachexia as confounding factors for the role of emphysema. [16] 
Conclusion
Our findings support the doubts expressed about emphysema being an independent risk factor for osteoporosis. Low BMI, severity of COPD and hypoxia play a dominant role. In the first reported multivariate model including these three factors (as well as age and CRP), emphysema was shown not to be an independent risk factor. 
